Avanza Fonder Ab Merck & Co., Inc. Transaction History
Avanza Fonder Ab
- $3.05 Trillion
- Q1 2025
A detailed history of Avanza Fonder Ab transactions in Merck & Co., Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 234,452 shares of MRK stock, worth $17.5 Million. This represents 0.67% of its overall portfolio holdings.
Number of Shares
234,452
Previous 273,453
14.26%
Holding current value
$17.5 Million
Previous $27.2 Billion
25.36%
% of portfolio
0.67%
Previous 0.81%
Shares
2 transactions
Others Institutions Holding MRK
# of Institutions
3,889Shares Held
1.93BCall Options Held
24.5MPut Options Held
21.4M-
Vanguard Group Inc Valley Forge, PA253MShares$18.9 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$15.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.02 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.11 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.46 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $189B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...